To Ensure Progress Against HIV, TB, Malaria, Donors Must Continue To Invest In Global Fund

Devex: Opinion: The world must invest in the fight against HIV, TB, malaria
Tedros Adhanom Ghebreyesus, director general of the WHO

“…Globally, the world has made incredible progress against HIV, TB, and malaria. But the job is not done. … Which is why we still need a strong and well-funded Global Fund. … [I]f current trends persist, we will miss [the Sustainable Development Goal targets of ending these three epidemics by 2030]. Progress against malaria has stalled, while the decline in HIV and TB cases and deaths is not moving fast enough. … In New Delhi this week, health leaders from around the world will gather to discuss the Global Fund’s investment case and its estimates of the impact that could be achieved if it meets its replenishment targets. … Despite the progress we have made against HIV, tuberculosis, and malaria, these three diseases remain a cause of enormous and preventable suffering and death. Apart from the lives they claim, they exact a heavy toll on health systems, sapping productivity and eroding economic growth. In New Delhi this week, the question is not whether the world can afford to invest in the Global Fund — it’s whether the world can afford not to” (2/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.